Authors


Anton Morrison

Latest:

The Evolving World of Pharma Marketing

Pharma companies that shift their attention to what providers, payers, and patients are asking for will profit from the growing worldwide market on preventative care.


Todd A. Lee, PharmD, PhD

Latest:

Devices Made Easy: A Review of Inhaler Technique and Patient Adherence in COPD

This Continuing Education activity is supported by educational grants from AstraZeneca LP and Boehringer Ingelheim Pharmaceuticals, Inc.



Abdalla Aly, PhD

Latest:

Payers' Views on the Heterogeneity of Treatment Effect in Oncology

When making coverage decisions in oncology, payers find difficulties in translating evidence on treatment effect heterogeneity into coverage policies.


Jeff Hull, BSPharm, RPh, Anthony J. Schueth, MS

Latest:

Health Information Technology: Supporting Pharmacy Trends in 2014

Four major trends will dominate the health information technology landscape during the coming year.


Jami Schell, PharmD, CSP

Latest:

Health-System Specialty Pharmacies Address Social Determinants of Health

Integrating specialty pharmacy staff into oncology, neurology, rheumatology, and other specialty clinics within their health systems is a growing trend with a range of beneficial outcomes.


Paul Sabatini, MEd, CPhT, FCSHP

Latest:

Techs Taking More Active Role in Preventing Poisonings

Pharmacy team members can provide educational resources, strategies to kids to promote safety.


John Fontanesi, PhD

Latest:

Comparison of Pharmacists and Primary Care Providers as Immunizers

Pharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.


Linda Lampi, PharmD, CSP, CPHQ

Latest:

Viability of a Dose Optimization Program Within a Specialty Pharmacy

Dose optimization strategies offer a potentially valid, clinically based intervention in which payers can realize a direct drug cost savings, and indirect medical cost avoidance.


Anyssa Garza, PharmD, BCMAS

Latest:

Vaccines: There Is an App for That

These 8 apps, offered by organizations such as the pediatric infectious diseases society and the CDC, feature vaccine schedules, risks, and more.


E. Thomas Carey, PharmD

Latest:

Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)

The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.


Mary Caffrey, American Journal of Managed Care

Latest:

Access to PCSK9 Inhibitors Still Restricted

At the American College of Cardiology Scientific Session, a study of prescriptions for PCSK9 inhibitors confirms what doctors say about trying to get their patients access to the cholesterol drug.



April M. Kunze, PharmD

Latest:

A Case for Biosimilar Use: 5 Things You Need to Know

Biosimilars are a potential solution to the ever-growing problem of high specialty drug costs.


The Generic Pharmaceutical Association

Latest:

Introduction: Reducing Our Nation's Health Care Costs

A revealing GPhA research report on brand name and generic prescription drug sales demonstrates how much generic medicines have saved consumers, as well as state and federal governments, over the past decade.


Julia Boyle, PharmD

Latest:

Attitudes, Barriers, and Perceptions Influence Naloxone Prescribing by Pharmacists

Evidence suggests that they are not actively using their prescriptive authority, but a new study aims to identify factors affecting their related behaviors.



Grant Gallagher

Latest:

Cost of PrEP May Inhibit Widespread Adoption

Although the use of preexposure prophylaxis against HIV has increased across the United States in recent years, the rise in costs across the health care system has yet to be fully catalogued.



Marie Smith, PharmD

Latest:

Low Reporting of Medicaid Diabetes Quality Measures: Room for Improvement?

In a review of publicly reported diabetes quality measures for Medicaid fee-for-service, overall reporting was low and reports of outcomes measures were rarely available.


Megan Daily

Latest:

New Ointment Found Effective in Eczema Treatment

Improvements in pruritus were achieved earlier with crisaborole for eczema.


Darius N. Lakdawalla, PhD

Latest:

The Role of Specialty Drugs in Private Sector Healthcare Spending

This study characterizes the role of specialty drug utilization in aggregate private sector healthcare spending in the United States from 2000 to 2009.


Aimee Faso, PharmD, BCOP, CPP

Latest:

GI Cancers: Neuroendocrine Cancer Update

Clinical trial results show that several new combination therapies offer great promise for the treatment of challenging neuroendocrine tumors in the gastrointestinal area.



Mary Anne Greenberg

Latest:

Behavioral-Based Communication Improves Patient Outcomes

Nonadherence is linked to poor health outcomes, including a decreased quality-of-life, disease progression, and increased hospitalizations.


Suzanne Tschida, PharmD, BCPS

Latest:

Improving Transplant Care Outcomes

For transplant patients, the difference between a successful and an unsuccessful outcome can be made by medication adherence.


Bhanu Gupta, MD

Latest:

Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting Strategy

This prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.


Tara Petersen, Editorial Director

Latest:

Technology Equals Opportunity: Seize the Moment

Whether its robots, microbots, smartphones, or 3-dimensional printing, the potential for technology to impact health care and pharmacy excites and motivates Dan Benamoz, RPh, founder and chief executive officer, Pharmacy Development Services.



Shannon W. Finks, PharmD

Latest:

The Road Less Traveled: Nontraditional Work Arrangements in Academia

According to the 2014 National Pharmacist Workforce Study, approximately 18.7% of women and 16.4% of men actively engaged as pharmacists reported working part-time.